MJBizDaily
How accessory sales reveal the future of cannabis retail
Featured
Latest Posts
As rescheduling fuels cannabis deals, integration decides who wins
Cannabis deals are won or lost after closing. Operators say start planning in due diligence and keep the local team that built the business.
News October 14Illinois cannabis sales increase to record levels amid price drop
Annual sales took a double-digit nosedive even as retailers saw their busiest month on record.
News October 13Canadian cannabis company Organigram enters fight for Aurora
British American Tobacco's stake in Organigram could put it in the middle of the Aurora takeover fight before Curaleaf's bid expires Dec. 4.
October 13Legacy medical cannabis cultivator Bedrocan declared bankrupt in Netherlands
A Dutch court on Thursday declared Bedrocan, the country's lone medical cannabis supplier, bankrupt following the end of its contract with the Netherlands' health ministry.
News October 9Federal marijuana rescheduling means institutional capital is coming to cannabis investing
The next stage of cannabis investing - institutional capital - is at hand thanks to federal marijuana rescheduling, but also thanks to a maturing industry.
News October 9Here’s what products Ohio cannabis stores can no longer sell
Ohio cannabis retailers can no longer sell certain products, including high potency vaporizers, after new state rules took effect Tuesday. In August, the DCC set new potency and package limits…
News October 8Washington state to tweak cannabis rules to comply with federal marijuana rescheduling
Washington state cannabis regulators signed off on a tweak to state rules that would allow operators to more clearly comply with new federal
News October 8How investing in cannabis worker training boosts operators’ margins
Kind Works founder Mskindness Ramirez explains how better training cuts turnover at cannabis retail stores.
News October 8Georgia medical cannabis continues to grow rapidly despite lack of DEA guidance
Georgia's medical cannabis program continues to rapidly expand, but state regulators say they need more input from the U.S. Drug Enforcement Administration.
News October 7












